Surgery offers best survival for early-stage lung cancer, study finds

Surgery should remain the primary treatment for people with early-stage non-small cell lung cancer (NSCLC) who are suitable for either surgery or a highly targeted form of radiotherapy, a new study from the London School of Hygiene & Tropical Medicine (LSHTM) suggests.